Paweł Lisewski

3.5k total citations
6 papers, 34 citations indexed

About

Paweł Lisewski is a scholar working on Neurology, Internal Medicine and Epidemiology. According to data from OpenAlex, Paweł Lisewski has authored 6 papers receiving a total of 34 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Neurology, 2 papers in Internal Medicine and 2 papers in Epidemiology. Recurrent topics in Paweł Lisewski's work include Acute Ischemic Stroke Management (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers) and Regulation of Appetite and Obesity (1 paper). Paweł Lisewski is often cited by papers focused on Acute Ischemic Stroke Management (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers) and Regulation of Appetite and Obesity (1 paper). Paweł Lisewski collaborates with scholars based in Poland, Spain and United Kingdom. Paweł Lisewski's co-authors include Michał Karliński, Anna Członkowska, Adam Kobayashi, Piotr Sobolewski, Waldemar Fryze, Tomasz Litwin, Walenty M. Nyka, Michał Szpinda, Karolina Szewczyk‐Golec and Jarosław Nuszkiewicz and has published in prestigious journals such as Cephalalgia, Metabolites and Neurologia i Neurochirurgia Polska.

In The Last Decade

Paweł Lisewski

5 papers receiving 32 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paweł Lisewski Poland	4	21	12	11	8	5	6	34
Sven Thonke Germany	3	19 0.9×	11 0.9×	11 1.0×	8 1.0×	2 0.4×	4	36
Daniel Giansante Abud Brazil	3	23 1.1×	11 0.9×	13 1.2×	11 1.4×	8 1.6×	5	29
Davar Nikneshan Canada	2	27 1.3×	11 0.9×	10 0.9×	9 1.1×	10 2.0×	2	39
Adam Kobayashi Poland	4	20 1.0×	13 1.1×	8 0.7×	12 1.5×	9 1.8×	9	37
Kristaps Jurjāns Latvia	4	24 1.1×	10 0.8×	10 0.9×	6 0.8×	5 1.0×	11	29
Marika Poulsen Denmark	2	25 1.2×	6 0.5×	15 1.4×	4 0.5×	5 1.0×	2	27
Wayne Collecutt New Zealand	4	35 1.7×	21 1.8×	11 1.0×	15 1.9×	8 1.6×	6	39
Mathieu Zuber France	2	21 1.0×	8 0.7×	10 0.9×	10 1.3×	11 2.2×	2	22
Oje Imoukhuede United States	2	25 1.2×	6 0.5×	9 0.8×	9 1.1×	14 2.8×	3	32
Marcin Głuszkiewicz Poland	3	32 1.5×	8 0.7×	17 1.5×	11 1.4×	8 1.6×	3	40

Countries citing papers authored by Paweł Lisewski

Since Specialization

Citations

This map shows the geographic impact of Paweł Lisewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paweł Lisewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paweł Lisewski more than expected).

Fields of papers citing papers by Paweł Lisewski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paweł Lisewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paweł Lisewski. The network helps show where Paweł Lisewski may publish in the future.

Co-authorship network of co-authors of Paweł Lisewski

This figure shows the co-authorship network connecting the top 25 collaborators of Paweł Lisewski. A scholar is included among the top collaborators of Paweł Lisewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paweł Lisewski. Paweł Lisewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Pozo‐Rosich, Patricia, Paweł Lisewski, Abdullah Nabi Aslan, et al.. (2025). A phase 4, randomized, double-blind, placebo-controlled trial evaluating the efficacy and tolerability of rimegepant for the prevention of episodic migraine in adults with a history of inadequate response to traditional oral preventive medications. Cephalalgia. 45(11). 2235436434–2235436434.

2.

Nuszkiewicz, Jarosław, et al.. (2024). Adipokines, Vitamin D, and Selected Inflammatory Biomarkers among Parkinson’s Disease Patients with and without Dyskinesia: A Preliminary Examination. Metabolites. 14(2). 106–106. 3 indexed citations

3.

Lisewski, Paweł, et al.. (2023). Changes in the Secretion of Melatonin and Selected Adipokines during the Progression of Parkinson’s Disease—Preliminary Studies. Metabolites. 13(5). 668–668. 5 indexed citations

4.

Karliński, Michał, Adam Kobayashi, Piotr Sobolewski, et al.. (2014). Is there a bad time for intravenous thrombolysis? The experience of Polish stroke centers. Neurologia i Neurochirurgia Polska. 48(1). 45–51. 3 indexed citations

5.

Karliński, Michał, Adam Kobayashi, Tomasz Litwin, et al.. (2012). Intravenous thrombolysis for acute ischaemic stroke in patients not fully adhering to the European licence in Poland. Neurologia i Neurochirurgia Polska. 46(1). 3–14. 19 indexed citations

6.

Szpinda, Michał, et al.. (2005). Morphometry of the pancreas in human foetuses.. PubMed. 64(1). 29–32. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact